These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15708090)

  • 1. p53 tumour suppressor gene and the tobacco industry.
    Boullin JM
    Lancet; 2005 Feb 12-18; 365(9459):567. PubMed ID: 15708090
    [No Abstract]   [Full Text] [Related]  

  • 2. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest.
    Bitton A; Neuman MD; Barnoya J; Glantz SA
    Lancet; 2005 Feb 5-11; 365(9458):531-40. PubMed ID: 15705463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 tumour suppressor gene and the tobacco industry.
    Phillips DH; Jenkinson P
    Lancet; 2005 Mar 19-25; 365(9464):1026; author reply 1026-7. PubMed ID: 15781091
    [No Abstract]   [Full Text] [Related]  

  • 4. [EBM and molecular biology from the perspective of lung cancer due to tobacco smoking].
    Nakanishi Y; Takayama K
    Nihon Naika Gakkai Zasshi; 2003 Jun; 92(6):1089-95. PubMed ID: 12866459
    [No Abstract]   [Full Text] [Related]  

  • 5. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients.
    Kondo K; Tsuzuki H; Sasa M; Sumitomo M; Uyama T; Monden Y
    J Surg Oncol; 1996 Jan; 61(1):20-6. PubMed ID: 8544455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco industry manipulation of research.
    Bero LA
    Public Health Rep; 2005; 120(2):200-8. PubMed ID: 15842123
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicine. A bumper crop of conflicts.
    Marshall E
    Science; 2008 May; 320(5876):602-3. PubMed ID: 18451276
    [No Abstract]   [Full Text] [Related]  

  • 8. Changing conclusions on secondhand smoke in a sudden infant death syndrome review funded by the tobacco industry.
    Tong EK; England L; Glantz SA
    Pediatrics; 2005 Mar; 115(3):e356-66. PubMed ID: 15741361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent research on tobacco control in Germany.
    Krämer A
    Am J Public Health; 2006 Jun; 96(6):956-7. PubMed ID: 16670211
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Science, industry, and tobacco harm reduction: a case study of tobacco industry scientists' involvement in the National Cancer Institute's Smoking and Health Program, 1964-1980.
    Parascandola M
    Public Health Rep; 2005; 120(3):338-49. PubMed ID: 16134578
    [No Abstract]   [Full Text] [Related]  

  • 12. p53 mutations and exposure to environmental tobacco smoke in a multicenter study on lung cancer.
    Husgafvel-Pursiainen K; Boffetta P; Kannio A; Nyberg F; Pershagen G; Mukeria A; Constantinescu V; Fortes C; Benhamou S
    Cancer Res; 2000 Jun; 60(11):2906-11. PubMed ID: 10850436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography screening for lung cancer in a high-risk population: update on current status.
    Russo P; Paleari L; Granone P; Cesario A; Pastorino U
    J Natl Cancer Inst; 2008 Jul; 100(14):1043-4. PubMed ID: 18612133
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tobacco and cancer: from epidemiological association to molecular evidence].
    To i Figueras J
    Med Clin (Barc); 1999 May; 112(15):589-94. PubMed ID: 10365388
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between smoking and p53 mutation in lung cancer: a meta-analysis.
    Liu X; Lin XJ; Wang CP; Yan KK; Zhao LY; An WX; Liu XD
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):18-24. PubMed ID: 24126199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The tobacco industry and the manipulation of scientific investigation. The case of European study of IARC-WHO related to tobacco passive consumption and lung cancer].
    González CA; Agudo A
    Med Clin (Barc); 2000 Sep; 115(8):302-4. PubMed ID: 11093886
    [No Abstract]   [Full Text] [Related]  

  • 17. Research from tobacco industry affiliated authors: need for particular vigilance.
    Chapman S
    Tob Control; 2005 Aug; 14(4):217-9. PubMed ID: 16046673
    [No Abstract]   [Full Text] [Related]  

  • 18. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers.
    Le Calvez F; Mukeria A; Hunt JD; Kelm O; Hung RJ; Tanière P; Brennan P; Boffetta P; Zaridze DG; Hainaut P
    Cancer Res; 2005 Jun; 65(12):5076-83. PubMed ID: 15958551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Naivety of researchers' and physicians' contacts with tobacco industry. Only a few are aware of the manipulation they are exposed to by well-conducted campaigns].
    Pershagen G
    Lakartidningen; 2002 Jun; 99(24):2726-8. PubMed ID: 12101596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.